Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy
Authors:
- John MalfetanoJMJohn Malfetano
- Trudy R. BakerTBTrudy R. Baker
- Ronald E. HemplingRHRonald E. Hempling
- 1 September 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 46 (3) , 357-360
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A phase II trial of adjuvant cisplatin and doxorubicin in Stage I epithelial ovarian cancerGynecologic Oncology, 1991
- Stage I ovarian epithelial carcinoma: Survival analysis following definitive treatmentGynecologic Oncology, 1991
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary reportGynecologic Oncology, 1989
- Treatment of Ovarian Carcinoma: Possibilities for ProgressNew England Journal of Medicine, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958